Inhibikase
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Inhibikase and other ETFs, options, and stocks.About IKT
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. It also focuses on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Ableson Tyrosine Kinases.
IKT Key Statistics
Stock Snapshot
Inhibikase(IKT) stock is priced at $1.74, giving the company a market capitalization of 220.28M. It carries a P/E multiple of -3.16.
On 2026-02-19, Inhibikase(IKT) stock moved within a range of $1.74 to $1.79. With shares now at $1.74, the stock is trading 0.0% above its intraday low and -2.8% below the session's peak.
Trading volume for Inhibikase(IKT) stock has reached 4.13K, versus its average volume of 892.03K.
Over the past 52 weeks, Inhibikase(IKT) stock has traded between a high of $3.32 and a low of $1.33.
Over the past 52 weeks, Inhibikase(IKT) stock has traded between a high of $3.32 and a low of $1.33.
Analyst ratings
100%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.